Qiming Venture Partners

Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Nan Chen

Principal

David Chu

Partner

Isaac Ciechanover

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Vice President

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho

Venture Partner

William Hu

Managing Partner

Duane Kuang

Co-Founder and Managing Partner

Nisa Leung

Managing Partner

Dingzheng Li

Vice President

Bin Liu

Vice President

Jing Liu

Vice President

Chang Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will McConnell

Principal

Gary Rieschel

Managing Partner

James Shen

Venture Partner

Motao Sun

Vice President

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Rachel Wang

Venture Partner

James Wang

Venture Partner

Xu Gillian

RMB funds CFO

Peter (Ming) Yin

Principal, Cleantech

Janet Yu

Partner

Oscar Zhang

Principal

Zhiyuan Zhou

Associate

Alex Zhou

Managing Partner

Yafeng Zhou

Associate

Zhifeng Zhou

Managing Partner

Phillip DiGiacomo Ph.D

Principal

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Past deals in Big Data

Zhipu AI

Venture Round in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Zhipu AI

Series D in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Thorough Future

Series A in 2024
Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.

Zhipu AI

Series B in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Leapstack

Series C in 2023
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.

Prime Lifescience

Seed Round in 2023
Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through digital technology innovation and the extensive application of artificial intelligence. Prime Lifescience offers a digital smart health community, an intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions environment, ultimately benefiting the healthcare sector through improved data-driven insights and collaboration.

Zhipu AI

Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Thorough Future

Series A in 2023
Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.

Cloud Technology

Venture Round in 2023
Cloud Technology is a multi-cloud and integrated data platform provider.

Biotree Technology

Series A in 2023
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.

Thorough Future

Series A in 2022
Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.

Biotree Technology

Series A in 2022
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.

Ashermed

Series B in 2022
Ashermed is a provider of contract research organization (CRO) services specifically designed for medical companies. The company emphasizes the integration of advanced technologies, such as Internet technology, big data, and artificial intelligence, to enhance the drug development process. By leveraging these technologies, Ashermed aims to shorten the clinical data development cycle and improve the quality of research outcomes, ultimately reducing research and development costs for its clients. Their offerings include CRO services, site management organization (SMO) support, patient recruitment, and digital platform assistance, all tailored to facilitate the needs of the medical industry.

Rhino Federated Computing

Venture Round in 2022
The value of connecting disparate datasets is immense, yet much of this potential remains untapped. Imagine the transformative possibilities: pharmaceutical companies sharing data to design better drugs and evaluate their real-world value, hospitals and HMOs diagnosing rare diseases faster, or financial institutions collaborating to combat financial crime. Rhino Federated Computing makes this vision a reality. Our federated computing platform, powered by advanced edge-computing and federated learning technologies, enables organizations to train and deploy AI models on massive, distributed datasets—without sharing sensitive information or compromising data privacy and sovereignty. This breakthrough approach was pioneered by our co-founder and CEO, Dr. Ittai Dayan, a recognized leader in the field whose work includes a landmark Nature Medicine publication in 2021.

Zhipu AI

Series B in 2022
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Prime Lifescience

Seed Round in 2022
Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through digital technology innovation and the extensive application of artificial intelligence. Prime Lifescience offers a digital smart health community, an intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions environment, ultimately benefiting the healthcare sector through improved data-driven insights and collaboration.

Tungee

Series B in 2021
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

DP Technology

Series B in 2021
DPTechnology, founded in 2018 and based in Beijing, China, specializes in micro-scale industrial design through advanced molecular simulation technology. The company has developed a platform that integrates artificial intelligence with molecular simulation algorithms, aiming to enhance industrial and medical research. By providing users with innovative scientific tools, DPTechnology promotes efficiency and creativity in exploring complex research challenges, thereby establishing a new paradigm in both industrial research and clinical applications.

Data Transmission Group

Secondary Market in 2021
Data Transmission Group is an Internet technology group focusing on big data services in the press and publishing industry. Data Transmission Group is committed to the digital transformation and upgrading of big data services in the press and publication industry and the digital transformation and upgrading of the media industry, creating a digital content profit model with content providers as the main commercial value, changing the way users acquire and disseminate knowledge, and leading the Internet + upgrade of China's news and publications Replacement and industrial development direction. At present, the group has nearly 200 employees, most of whom are senior publishing, Internet, and software R&D personnel. They have a complete independent R&D system and have rich research results in mobile Internet technology, storage technology, data mining, and publishing integration.

Tungee

Series C in 2021
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

Tungee

Series B in 2020
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

New Horizon Health

Series E in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

New Horizon Health

Series D in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

NVX Clouds Tech

Series A in 2020
NVX Clouds Tech is an artificial intelligence security computing company focused on data privacy protection. It utilizes unique privacy computing technology to fully protect local and cloud data privacy and security through the Cing Weixin privacy cloud computing platform and all-in-one product line. It also provides solutions for the protection of big data security and commercial secrets in finance. The company aims to build a privacy computing platform for big data, separate the ownership, management, and use rights of the data, fully realize the flow of data, and promote the fourth industrial revolution.

Club Factory

Series D in 2019
Club Factory is an online shopping platform that facilitates cross-border e-commerce by connecting consumers directly with manufacturers. By leveraging big data and artificial intelligence, the company scans the internet to identify factories that sell products on various platforms such as Wish, eBay, and Amazon. This allows Club Factory to compare prices from multiple sources, ultimately presenting customers with the lowest available prices. In addition to enhancing the shopping experience for consumers, the company also provides supply chain management solutions for enterprises, enabling them to optimize their operations and improve cost efficiency.

Tungee

Series B in 2019
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

New Horizon Health

Series C in 2019
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Reelsky Data Systems

Series A in 2018
Reelsky Data Systems is a provider and developer of data modeling and analysis services tailored for the credit rating industry. The company specializes in research and development focused on big data analysis, offering customized solutions to financial institutions. Its service offerings include consultation, data services, platform services, and technical support. Reelsky Data Systems also produces a range of products, including marketing and risk control systems, as well as a cloud-based decision service. The emphasis on high-standard services enables the company to meet the specific needs of its clients in the evolving financial landscape.

Eigen

Series B in 2018
Eigen Technologies, Inc. is a provider of artificial intelligence services based in Hangzhou, China. The company focuses on applying advanced AI technologies across various business domains, emphasizing natural language understanding, knowledge graphs, and deep learning. By leveraging these technologies, Eigen aims to enhance user experiences and drive innovation, offering industries solutions for big data analysis rooted in artificial intelligence.

SequoiaDB

Series C in 2018
SequoiaDB Corporation is a distributed database company based in Shenzhen, China, founded in 2011. It specializes in developing enterprise-class distributed relational databases, notably SequoiaDB, designed for core online transactions, data center operations, and content management. The company also offers SequoiaCM, an enterprise content management solution that addresses the challenges of storing and managing large volumes of unstructured data for medium and large enterprises. SequoiaDB's suite of products supports various applications, including online transaction businesses and data lake solutions, and it primarily serves clients in the financial sector, such as banks, insurance companies, and securities firms. The company has gained recognition in the database industry for its innovative approach and has been featured in Gartner’s reports as a leading provider of advanced database systems.

Tungee

Series A in 2018
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

Infervision

Series B in 2018
Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

XiaoMan Technology

Series C in 2018
XiaoMan Technology is a foreign trade solutions provider based in Shenzhen, China, established in 2013. The company specializes in developing software-as-a-service (SaaS) business management solutions that leverage big data and artificial intelligence. Its offerings include customer relationship management technology designed to assist enterprises in expanding their international operations. XiaoMan's products and services are characterized by their flexibility and compatibility, catering to both small and micro enterprises as well as larger organizations with specific customization needs. By employing a comprehensive, customer-focused system for research and development, customer service, sales, and marketing, XiaoMan Technology aims to deliver high-quality solutions that enhance customer service, boost sales productivity, and facilitate customer acquisition for its clients.

Eigen

Series B in 2017
Eigen Technologies, Inc. is a provider of artificial intelligence services based in Hangzhou, China. The company focuses on applying advanced AI technologies across various business domains, emphasizing natural language understanding, knowledge graphs, and deep learning. By leveraging these technologies, Eigen aims to enhance user experiences and drive innovation, offering industries solutions for big data analysis rooted in artificial intelligence.

Infervision

Series B in 2017
Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

New Horizon Health

Series B in 2017
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Kuaile Zhihui

Series A in 2017
Kuaile Zhihui, which means “happiness and intelligence”, is a Beijing-based artificial intelligence start-up developing educational robots for children. The company develops educational robots for kindergarten and primary school students, employing speech recognition, big data analysis, and deep learning. Its robots teach math, Chinese and English, and can adjust course content by evaluating a child’s learning ability based on its big data analysis system. Kuaile Zhihui was founded in 2015 by Lei Ming, former chief architect at Baidu Inc. and founder of music site Kuwo.

XiaoMan Technology

Series B in 2016
XiaoMan Technology is a foreign trade solutions provider based in Shenzhen, China, established in 2013. The company specializes in developing software-as-a-service (SaaS) business management solutions that leverage big data and artificial intelligence. Its offerings include customer relationship management technology designed to assist enterprises in expanding their international operations. XiaoMan's products and services are characterized by their flexibility and compatibility, catering to both small and micro enterprises as well as larger organizations with specific customization needs. By employing a comprehensive, customer-focused system for research and development, customer service, sales, and marketing, XiaoMan Technology aims to deliver high-quality solutions that enhance customer service, boost sales productivity, and facilitate customer acquisition for its clients.

SequoiaDB

Series B in 2016
SequoiaDB Corporation is a distributed database company based in Shenzhen, China, founded in 2011. It specializes in developing enterprise-class distributed relational databases, notably SequoiaDB, designed for core online transactions, data center operations, and content management. The company also offers SequoiaCM, an enterprise content management solution that addresses the challenges of storing and managing large volumes of unstructured data for medium and large enterprises. SequoiaDB's suite of products supports various applications, including online transaction businesses and data lake solutions, and it primarily serves clients in the financial sector, such as banks, insurance companies, and securities firms. The company has gained recognition in the database industry for its innovative approach and has been featured in Gartner’s reports as a leading provider of advanced database systems.

KingTrol Data

Series A in 2016
KingTrol Data specializes in automatic control system maintenance and information system operation and maintenance services. The company integrates big data technology to offer solutions that assist businesses in conserving energy and enhancing operational efficiency. By focusing on small and medium-sized water companies, KingTrol Data aims to facilitate industrial energy-saving transformations and deliver data-centric application services. Customer inquiries are efficiently addressed through various communication channels, including phone, email, and online applications.

FraudMetrix

Series C in 2016
Hangzhou FraudMetrix is a Chinese company engaged in the development of security products against internet risks and fraud. FraudMetrix is dedicated to solving problems such as internet risks and fraud, so as to bring value for enterprises with data intelligence. It covers antifraud areas including account fraud, transaction fraud, payment fraud, business fraud, internet credit fraud, and corporate internal fraud. FraudMetrix is focused on catering to the diversified needs of corporate risk management. FraudMetrix was founded in 2013 by a group of antifraud scientists and technology executives of the former Ali Group Security Department, PayPal, and RSA.

Transwarp

Series B in 2016
Transwarp is a technology company based in Shanghai that specializes in big data software solutions for enterprises. It offers a cloud-based platform that serves as an integrated system for data processing and cloud operations. This platform facilitates the management and analysis of data, allowing businesses to effectively store and govern their data throughout its entire life cycle. Additionally, Transwarp provides services related to data integration, modeling, analysis, mining, and circulation, enabling organizations to harness the full potential of their data infrastructure.

Qiniu

Series D in 2016
Qiniu Cloud is a leading enterprise cloud service provider in China. It is committed to driving social industry development with cloud technology, and it focuses on the cloud computing industry with data intelligence and visual intelligence as its core. Through massive data and rich media scenarios across industries, Qiniu Cloud launches the intelligent video cloud integrated with CDN, object storage, cloud host, big data, content recognition platform and other product portfolios, which provides comprehensive cloud computing service for users. More than one million enterprise-level clients are using qiniu cloud to provide services for 80% of the Internet users nationwide. It provides cloud plus smart technology empowerment for users in various industries to meet the new opportunities of Artificial Intelligence and the arrival of 5G era.

Oakbarrel

Series B in 2015
Oakbarrel is a financial planner platform that focuses on financial services and big data.

Financial Information Management

Series A in 2015
Supplier of analytical software trading tools intended to provide accurate, real-time market data. The company's technical analysis and fundamental information tool enables most energy companies and large agricultural trading firms to manage, filter and quickly analyze pricing, trends and news, that is crucial to making informed and profitable trading decisions. It also provides server and middleware tools, as well as a rich set of web services for customers integrating financial information and analysis of their enterprise-wide systems.

FraudMetrix

Series B in 2015
Hangzhou FraudMetrix is a Chinese company engaged in the development of security products against internet risks and fraud. FraudMetrix is dedicated to solving problems such as internet risks and fraud, so as to bring value for enterprises with data intelligence. It covers antifraud areas including account fraud, transaction fraud, payment fraud, business fraud, internet credit fraud, and corporate internal fraud. FraudMetrix is focused on catering to the diversified needs of corporate risk management. FraudMetrix was founded in 2013 by a group of antifraud scientists and technology executives of the former Ali Group Security Department, PayPal, and RSA.

Transwarp

Series A in 2015
Transwarp is a technology company based in Shanghai that specializes in big data software solutions for enterprises. It offers a cloud-based platform that serves as an integrated system for data processing and cloud operations. This platform facilitates the management and analysis of data, allowing businesses to effectively store and govern their data throughout its entire life cycle. Additionally, Transwarp provides services related to data integration, modeling, analysis, mining, and circulation, enabling organizations to harness the full potential of their data infrastructure.

SequoiaDB

Series A in 2014
SequoiaDB Corporation is a distributed database company based in Shenzhen, China, founded in 2011. It specializes in developing enterprise-class distributed relational databases, notably SequoiaDB, designed for core online transactions, data center operations, and content management. The company also offers SequoiaCM, an enterprise content management solution that addresses the challenges of storing and managing large volumes of unstructured data for medium and large enterprises. SequoiaDB's suite of products supports various applications, including online transaction businesses and data lake solutions, and it primarily serves clients in the financial sector, such as banks, insurance companies, and securities firms. The company has gained recognition in the database industry for its innovative approach and has been featured in Gartner’s reports as a leading provider of advanced database systems.

Qiniu

Series C in 2014
Qiniu Cloud is a leading enterprise cloud service provider in China. It is committed to driving social industry development with cloud technology, and it focuses on the cloud computing industry with data intelligence and visual intelligence as its core. Through massive data and rich media scenarios across industries, Qiniu Cloud launches the intelligent video cloud integrated with CDN, object storage, cloud host, big data, content recognition platform and other product portfolios, which provides comprehensive cloud computing service for users. More than one million enterprise-level clients are using qiniu cloud to provide services for 80% of the Internet users nationwide. It provides cloud plus smart technology empowerment for users in various industries to meet the new opportunities of Artificial Intelligence and the arrival of 5G era.

Qiniu

Series B in 2013
Qiniu Cloud is a leading enterprise cloud service provider in China. It is committed to driving social industry development with cloud technology, and it focuses on the cloud computing industry with data intelligence and visual intelligence as its core. Through massive data and rich media scenarios across industries, Qiniu Cloud launches the intelligent video cloud integrated with CDN, object storage, cloud host, big data, content recognition platform and other product portfolios, which provides comprehensive cloud computing service for users. More than one million enterprise-level clients are using qiniu cloud to provide services for 80% of the Internet users nationwide. It provides cloud plus smart technology empowerment for users in various industries to meet the new opportunities of Artificial Intelligence and the arrival of 5G era.

Qiniu

Series A in 2012
Qiniu Cloud is a leading enterprise cloud service provider in China. It is committed to driving social industry development with cloud technology, and it focuses on the cloud computing industry with data intelligence and visual intelligence as its core. Through massive data and rich media scenarios across industries, Qiniu Cloud launches the intelligent video cloud integrated with CDN, object storage, cloud host, big data, content recognition platform and other product portfolios, which provides comprehensive cloud computing service for users. More than one million enterprise-level clients are using qiniu cloud to provide services for 80% of the Internet users nationwide. It provides cloud plus smart technology empowerment for users in various industries to meet the new opportunities of Artificial Intelligence and the arrival of 5G era.

Rhino Federated Computing

The value of connecting disparate datasets is immense, yet much of this potential remains untapped. Imagine the transformative possibilities: pharmaceutical companies sharing data to design better drugs and evaluate their real-world value, hospitals and HMOs diagnosing rare diseases faster, or financial institutions collaborating to combat financial crime. Rhino Federated Computing makes this vision a reality. Our federated computing platform, powered by advanced edge-computing and federated learning technologies, enables organizations to train and deploy AI models on massive, distributed datasets—without sharing sensitive information or compromising data privacy and sovereignty. This breakthrough approach was pioneered by our co-founder and CEO, Dr. Ittai Dayan, a recognized leader in the field whose work includes a landmark Nature Medicine publication in 2021.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.